Cargando…

Interleukin-6 (IL-6) inhibitors as therapeutic agents for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis

INTRODUCTION: Preliminary studies showed that coronavirus disease 2019 (COVID-19) disrupts body immune system, including dysregulation of cytokine interleukin-6 (IL-6). IL-6 inhibitors agents have been used as treatment options for COVID-19, yet their benefit as therapeutic agents remains unclear. O...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinzon, Rizaldy Taslim, Wijaya, Vincent Ongko, Buana, Ranbebasa Bijak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204364/ https://www.ncbi.nlm.nih.gov/pubmed/34153723 http://dx.doi.org/10.1016/j.jiph.2021.06.004

Ejemplares similares

Neurologic Characteristics in Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis
por: Pinzon, Rizaldy Taslim, et al.
Publicado: (2020)

Bridging the gap of knowledge and skills for diagnosis and treatment of painful neuropathy: Development and evaluation of pain education project for clinicians in primary care settings
por: Pinzon, Rizaldy Taslim, et al.
Publicado: (2022)

Persistent neurological manifestations in long COVID-19 syndrome: A systematic review and meta-analysis
por: Pinzon, Rizaldy Taslim, et al.
Publicado: (2022)

Encephalitis due to miliary tuberculosis in a patient with human immunodeficiency virus: A case report
por: Pinzon, Rizaldy Taslim, et al.
Publicado: (2021)

The Benefits of Add-on Therapy of Vitamin D 5000 IU to the Vitamin D Levels and Symptoms in Diabetic Neuropathy Patients: A Randomized Clinical Trial
por: Pinzon, Rizaldy Taslim, et al.
Publicado: (2021)

The role of homocysteine levels as a risk factor of ischemic stroke events: a systematic review and meta-analysis
por: Pinzon, Rizaldy Taslim, et al.
Publicado: (2023)

Effects of Eperisone Hydrochloride and Non-Steroid Anti-Inflammatory Drugs (NSAIDs) for Acute Non-Specific Back Pain with Muscle Spasm: A Prospective, Open-Label Study
por: Pinzon, Rizaldy Taslim, et al.
Publicado: (2020)

Effect of DLBS1033 on Functional Outcomes for Patients with Acute Ischemic Stroke: A Randomized Controlled Trial
por: Pinzon, Rizaldy Taslim, et al.
Publicado: (2021)

Foster Kennedy syndrome caused by tuberculous brain abscess: A case report
por: Pinzon, Rizaldy Taslim, et al.
Publicado: (2021)

Medical comorbidities as predictors of COVID-19 short-term mortality: A historical cohort study in Indonesia
por: Pinzon, Rizaldy Taslim, et al.
Publicado: (2022)

Hydrocephalus Caused by Tuberculous Meningitis in an Immunocompetent Young Adult: A Case Report
por: Pinzon, Rizaldy Taslim, et al.
Publicado: (2023)

Prevalence of Aspirin and Clopidogrel Resistance in Patients with Recurrent Ischaemic Cerebrovascular Disease
por: Karunawan, Niyata Hananta, et al.
Publicado: (2021)

Vitamin D deficiency among patients with COVID-19: case series and recent literature review
por: Pinzon, Rizaldy Taslim, et al.
Publicado: (2020)

Ischemic Stroke following COVID-19 in a Patient without Comorbidities
por: Pinzon, Rizaldy Taslim, et al.
Publicado: (2021)

Ischemic Stroke Following Calloselasma rhodostoma Snakebite: A Rare Case Report
por: Pinzon, Rizaldy Taslim, et al.
Publicado: (2022)

Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
por: Liu, Bingwen, et al.
Publicado: (2020)

The role of interleukin‐6 in monitoring severe case of coronavirus disease 2019
por: Liu, Tao, et al.
Publicado: (2020)

Special issue on Interleukin-6 (IL-6)
por: Rincon, Mercedes
Publicado: (2012)

Sepsis-associated severe interleukin-6 storm in critical coronavirus disease 2019
por: Huang, Lan, et al.
Publicado: (2020)

Interleukin-6 level, right ventricular systolic dysfunction, and coronavirus disease 2019
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Elevated interleukin‐6, interleukin‐10 and neutrophil : lymphocyte ratio as identifiers of severe coronavirus disease 2019
por: Godkin, Andrew, et al.
Publicado: (2020)

Potential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancer
por: Heo, Tae-Hwe, et al.
Publicado: (2016)

Role of interleukin 4 (IL4) and interleukin 6 (IL6) in the pathogenesis and prognosis of childhood primary immune thrombocytopenia
por: Zakaria, Marwa, et al.
Publicado: (2023)

Variability, Expression, and Methylation of IL-6 and IL-8 Genes in Bladder Cancer Pathophysiology
por: Grębowski, Radosław, et al.
Publicado: (2023)

Cathepsin S provokes interleukin-6 (IL-6) trans-signaling through cleavage of the IL-6 receptor in vitro
por: Flynn, Charlotte M., et al.
Publicado: (2020)

Role of interleukin-6 (IL-6) in predicting gestational diabetes mellitus
por: Amirian, Azam, et al.
Publicado: (2020)

A Non-severe Coronavirus Disease 2019 Patient With Persistently High Interleukin-6 Level
por: Hambali, Nurfarah Lydia, et al.
Publicado: (2020)

Interleukin-6 in Critical Coronavirus Disease 2019, a Driver of Lung Inflammation of Systemic Origin?
por: Aarskog, Nikolai Ravn, et al.
Publicado: (2021)

Interleukin-6 Trajectory and Secondary Infections in Mechanically Ventilated Patients With Coronavirus Disease 2019 Acute Respiratory Distress Syndrome Treated With Interleukin-6 Receptor Blocker
por: Vazquez Guillamet, M. Cristina, et al.
Publicado: (2021)

Interleukin‐6 signaling requires only few IL‐6 molecules: Relation to physiological concentrations of extracellular IL‐6
por: Hansen, Morten B.
Publicado: (2020)

Interleukin-6 inhibitors reduce mortality in coronavirus disease-2019: An individual patient data meta-analysis from randomized controlled trials
por: Tasoudis, Panagiotis T., et al.
Publicado: (2022)

The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL- 6 and prolongation of the plasma half-life of IL-6
Publicado: (1996)

Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies
por: Tawara, Ken, et al.
Publicado: (2011)

Structural Mimicry of Receptor Interaction by Antagonistic Interleukin-6 (IL-6) Antibodies
por: Blanchetot, Christophe, et al.
Publicado: (2016)

Interleukin-6 (IL-6) Receptor Antagonist Protects Against Rheumatoid Arthritis
por: Li, Songsong, et al.
Publicado: (2016)

Tocilizumab does not block interleukin-6 (IL-6) signaling in murine cells
por: Lokau, Juliane, et al.
Publicado: (2020)

Liver Injury in Patients Hospitalized with Coronavirus Disease 2019 Correlates with Hyperinflammatory Response and Elevated Interleukin‐6
por: Da, Ben L., et al.
Publicado: (2020)

Reply to letter to the editor: “Interleukin-6 level, right ventricular systolic dysfunction, and coronavirus disease 2019”
por: Erdoğan, Mehmet, et al.
Publicado: (2022)

Assessment of Interleukins IL-4, IL-6, IL-8, IL-10 in Acute Urticaria
por: Papadopoulos, Jordan, et al.
Publicado: (2014)

Acute dizziness and mental alteration associated with Moderna COVID-19 vaccine: a case report
por: Pinzon, Rizaldy Taslim, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ms3skl9vgphpvbcpa7p3r94c5a